insights_auto
Nega 4559 tushdi 2,72%?
Batafsil oʻrganishchevron_right
4559:TYO
Zeria Pharmaceutical Co Ltd
1 898,00 JP¥
arrow_downward
-2,72%(-53,00) 1K
2-okt, 15:30:00 (GMT+9) · JPY
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto4559 tikeri uchun statistika yaratilmoqda...
Ochish
1 938 JP¥
Yuqori
1 938 JP¥
Past
1 895 JP¥
Bozor kapitali
95,13 mlrd
Oʻrtacha hajm
162,22 ming
Hajmi
240,70 ming
Dividend
2,58%
Choraklik dividendlar
12 JP¥
Eks-dividend sanasi
29-sen, 2026
P/E koeffitsiyenti
10,17
52 haftalik eng yuqori
2 434 JP¥
52 haftalik eng past
1 878 JP¥
Aksiya boʻyicha daromad
187 JP¥
Muomaladagi aksiyalar
50,11 mln
Xodimlar soni
2 ming
Ochish
1 938 JP¥
Yuqori
1 938 JP¥
Past
1 895 JP¥
Bozor kapitali
95,13 mlrd
Oʻrtacha hajm
162,22 ming
Hajmi
240,70 ming
Dividend
2,58%
Choraklik dividendlar
12 JP¥
Eks-dividend sanasi
29-sen, 2026
P/E koeffitsiyenti
10,17
52 haftalik eng yuqori
2 434 JP¥
52 haftalik eng past
1 878 JP¥
Aksiya boʻyicha daromad
187 JP¥
Muomaladagi aksiyalar
50,11 mln
Xodimlar soni
2 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
23 daqiqa oldin
What Ramaco Resources Holders Had To Sit Through
TradingView
·
1 soat oldin
AI spending to drive another strong S&P 500 earnings season, Goldman Sachs says
Profil
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Zeria Pharmaceutical Co Ltd haqida
CEOSachiaki Ibe
Xodimlar soni1,75 ming
Asos solingan22-dek, 1955
Bosh ofislar-
Sektor-
Veb-saytzeria.co.jp